Genome profiling of ERBB2-amplified breast cancers

Loss of full length CtBP1 expression enhances the invasive potential of human melanoma

(2009) Andreas Winklmeier et al.   BMC CANCER

Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers

(2009) R. Natrajan et al.   CLINICAL CANCER RESEARCH

FOXA1 in breast cancer

(2009) Harikrishna Nakshatri et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

Alterations in the TOP2A and HER2 Genes: Association With Adjuvant Anthracycline Sensitivity in Human Breast Cancers

(2009) D. J. Slamon et al.   JNCI-Journal of the National Cancer Institute

Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores

(2009) Foluso O Ademuyiwa et al.   MODERN PATHOLOGY

High-resolution array CGH clarifies events occurring on 8p in carcinogenesis

(2008) Susanna L Cooke et al.   BMC CANCER

Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease

(2008) M W Helms et al.   BRITISH JOURNAL OF CANCER

A Range of Cancers Is Associated with the rs6983267 Marker on Chromosome 8

(2008) D. Wokolorczyk et al.   CANCER RESEARCH

Mel-18 Negatively Regulates INK4a/ARF-Independent Cell Cycle Progression via Akt Inactivation in Breast Cancer

(2008) J.-Y. Lee et al.   CANCER RESEARCH

Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population

(2008) Kristy E. Driver et al.   CARCINOGENESIS

Impact of Insulin-Like Growth Factor Type 1 Receptor, Epidermal Growth Factor Receptor, and HER2 Expressions on Outcomes of Patients with Gastric Cancer

(2008) J. Matsubara et al.   CLINICAL CANCER RESEARCH

Absence of ESR1 amplification in a series of breast cancers

(2008) José Adélaïde et al.   INTERNATIONAL JOURNAL OF CANCER

HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy

(2008) Kathleen I. Pritchard et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy

(2008) Stephen Johnston et al.   JOURNAL OF CLINICAL ONCOLOGY

Cross-Talk Between the ErbB/HER Family and the Type I Insulin-Like Growth Factor Receptor Signaling Pathway in Breast Cancer

(2008) Quanri Jin et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

The genomic profile ofHER2-amplified breast cancers: the influence of ER status

(2008) C Marchiò et al.   JOURNAL OF PATHOLOGY

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

(2008) Edurne Arriola et al.   LABORATORY INVESTIGATION

The Identification of MicroRNAs in a Genomically Unstable Region of Human Chromosome 8q24

(2008) K. Huppi et al.   MOLECULAR CANCER RESEARCH

A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3

(2008) Ian PM Tomlinson et al.   NATURE GENETICS

Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

(2008) Montserrat Garcia-Closas et al.   PLoS Genetics

FoxA1 as a lineage-specific oncogene in luminal type breast cancer

(2007) Noritaka Yamaguchi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS